y 590 has been researched along with indolidan in 1 studies
Studies (y 590) | Trials (y 590) | Recent Studies (post-2010) (y 590) | Studies (indolidan) | Trials (indolidan) | Recent Studies (post-2010) (indolidan) |
---|---|---|---|---|---|
5 | 0 | 0 | 25 | 1 | 0 |
Protein | Taxonomy | y 590 (IC50) | indolidan (IC50) |
---|---|---|---|
cAMP-specific 3',5'-cyclic phosphodiesterase 4A | Homo sapiens (human) | 0.15 | |
cAMP-specific 3',5'-cyclic phosphodiesterase 4B | Homo sapiens (human) | 0.15 | |
cAMP-specific 3',5'-cyclic phosphodiesterase 4C | Homo sapiens (human) | 0.15 | |
cAMP-specific 3',5'-cyclic phosphodiesterase 4D | Homo sapiens (human) | 0.15 | |
cGMP-inhibited 3',5'-cyclic phosphodiesterase B | Homo sapiens (human) | 3.54 | |
cGMP-inhibited 3',5'-cyclic phosphodiesterase A | Homo sapiens (human) | 3.54 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beedle, EE; Hayes, JS; Kauffman, RF; Krushinski, JH; Pollock, GD; Robertson, DW; Wilson, H; Wyss, V | 1 |
1 other study(ies) available for y 590 and indolidan
Article | Year |
---|---|
Dihydropyridazinone cardiotonics: the discovery and inotropic activity of 1,3-dihydro-3,3-dimethyl-5-(1,4,5,6-tetrahydro-6-oxo-3-pyridazinyl)-2H -indol-2- one.
Topics: Administration, Oral; Animals; Cardiotonic Agents; Cats; Dogs; Female; In Vitro Techniques; Indoles; Male; Myocardial Contraction; Oxindoles; Platelet Aggregation; Pyridazines; Structure-Activity Relationship | 1986 |